These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 37048650)

  • 1. Gut Failure: A Review of the Pathophysiology and Therapeutic Potentials in the Gut-Heart Axis.
    Matsiras D; Bezati S; Ventoulis I; Verras C; Parissis J; Polyzogopoulou E
    J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota in heart failure and related interventions.
    Chen AT; Zhang J; Zhang Y
    Imeta; 2023 Aug; 2(3):e125. PubMed ID: 38867928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Microbiome in Heart Failure.
    Kitai T; Kirsop J; Tang WH
    Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMAO: how gut microbiota contributes to heart failure.
    Zhang Y; Wang Y; Ke B; Du J
    Transl Res; 2021 Feb; 228():109-125. PubMed ID: 32841736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay Between Gut Microbiota and Amino Acid Metabolism in Heart Failure.
    Tuerhongjiang G; Guo M; Qiao X; Lou B; Wang C; Wu H; Wu Y; Yuan Z; She J
    Front Cardiovasc Med; 2021; 8():752241. PubMed ID: 34746265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review.
    Mamic P; Chaikijurajai T; Tang WHW
    J Mol Cell Cardiol; 2021 Mar; 152():105-117. PubMed ID: 33307092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and integrative traditional Chinese and western medicine in prevention and treatment of heart failure.
    Cui H; Han S; Dai Y; Xie W; Zheng R; Sun Y; Xia X; Deng X; Cao Y; Zhang M; Shang H
    Phytomedicine; 2023 Aug; 117():154885. PubMed ID: 37302262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Diet on Gut Microbiota Composition and Microbiota-Associated Functions in Heart Failure: A Systematic Review of In Vivo Animal Studies.
    Palombaro M; Raoul P; Cintoni M; Rinninella E; Pulcini G; Aspromonte N; Ianiro G; Gasbarrini A; Mele MC
    Metabolites; 2022 Dec; 12(12):. PubMed ID: 36557307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Gut Microbiota in Heart Failure: Trying to Unmask an Emerging Organ.
    Paraskevaidis I; Xanthopoulos A; Tsougos E; Triposkiadis F
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37761015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure.
    Kamo T; Akazawa H; Suzuki JI; Komuro I
    Korean Circ J; 2017 Sep; 47(5):663-669. PubMed ID: 28955383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiome and heart failure: A better gut for a better heart.
    Branchereau M; Burcelin R; Heymes C
    Rev Endocr Metab Disord; 2019 Dec; 20(4):407-414. PubMed ID: 31705258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-Chain Fatty Acids in Gut-Heart Axis: Their Role in the Pathology of Heart Failure.
    Yukino-Iwashita M; Nagatomo Y; Kawai A; Taruoka A; Yumita Y; Kagami K; Yasuda R; Toya T; Ikegami Y; Masaki N; Ido Y; Adachi T
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
    Belli M; Barone L; Longo S; Prandi FR; Lecis D; Mollace R; Margonato D; Muscoli S; Sergi D; Federici M; Barillà F
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?
    Chaikijurajai T; Tang WHW
    Curr Heart Fail Rep; 2021 Apr; 18(2):23-32. PubMed ID: 33559845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.
    Nagatomo Y; Tang WH
    J Card Fail; 2015 Dec; 21(12):973-80. PubMed ID: 26435097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut and intestinal bacteria in chronic heart failure.
    Sandek A; Anker SD; von Haehling S
    Curr Drug Metab; 2009 Jan; 10(1):22-8. PubMed ID: 19149510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease.
    Huang Y; Xin W; Xiong J; Yao M; Zhang B; Zhao J
    Front Pharmacol; 2022; 13():837500. PubMed ID: 35370631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure.
    Anderson KM; Ferranti EP; Alagha EC; Mykityshyn E; French CE; Reilly CM
    Heart Fail Rev; 2022 Nov; 27(6):2223-2249. PubMed ID: 35726110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure.
    Nendl A; Raju SC; Broch K; Mayerhofer CCK; Holm K; Halvorsen B; Lappegård KT; Moscavitch S; Hov JR; Seljeflot I; Trøseid M; Awoyemi A
    Front Cardiovasc Med; 2023; 10():1160030. PubMed ID: 37332580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.